- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Savient Pharmaceuticals Inc
Add to PortfolioSVNT:US
0.8592 USD 0.0992 13.05%As of 20:10:00 ET on 05/25/2012.
Snapshot for Savient Pharmaceuticals Inc (SVNT)
| Open: | 0.7606 | Day's Range: | 0.7500 - 0.9090 | Volume: | 1,265,517 | Bid: | 0.8592 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 0.7600 | 52wk Range: | 0.7500 - 8.4900 | 1-Yr Rtn: | -89.50% | Ask: | 0.8600 |
Key Statistics for SVNT
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (USD) (ttm) | -1.7500 |
| Est. EPS (USD) (12/2012) | -1.6970 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 62.20 |
| Shares Outstanding (M) | 72.39 |
| Enterprise Value (M USD) (ttm) | 108.34 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 5.1110 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/03/2012 |
More SVNT Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for SVNT
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for SVNT
Savient Pharmaceuticals Inc. develops, manufactures, and markets human health care products for niche and wider markets. The Company offers pharmaceutical products for a wide range of medical needs such as weight gain, drugs targeting the control of elevated uric acid levels in the blood, and rheumatology.
| Stephen O JaegerChairman | David Y NortonInterim Chief Executive Ofcr |
| David VeitchPresident:Europe | Kenneth M BahrtSenior VP/Chief Medical Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page